24–25 Nov 2026
IARC
Europe/Paris timezone

Contribution List

28 out of 28 displayed
  1. Josefina Orliacq (ENV)
    24/11/2026, 09:15
  2. Loucine Sazian (IARC)
    24/11/2026, 09:30
    Cancer Etiology, Epidemiology & Risk Factors
    Extended oral

    Background/Aim: As tattooing becomes increasingly popular worldwide, its potential contribution to blood-borne viral infections remains a public health concern. Hepatitis B (HBV) and C (HCV) infections are major causes of liver cancer. We aimed to quantify the associations between tattooing and HBV/HCV infection globally and examine their consistency across populations and geographical...

    Go to contribution page
  3. Dr Alem Abraha (IARC)
    24/11/2026, 09:50
    Cancer Etiology, Epidemiology & Risk Factors
    Short oral

    Background: Physical activity (PA) and diet are key modifiable lifestyle factors influencing obesity. Understanding the transition from preclinical to clinical obesity is important because clinical obesity is associated with substantially greater health risks. However, the role of lifestyle factors in this transition remains poorly understood. We assessed the independent and joint associations...

    Go to contribution page
  4. Leonie Courcoul (IARC)
    24/11/2026, 10:05
    Cancer Etiology, Epidemiology & Risk Factors
    Short oral

    Background: Repeated measurements are increasingly available in epidemiological cohorts, creating opportunities to investigate whether exposures at different ages contribute differently to later health outcomes. However, exposure histories are often reduced to a single summary measure, limiting the ability to identify sensitive periods across the life course.

    Methods: We extended a...

    Go to contribution page
  5. Felix Boekstegers (IARC)
    24/11/2026, 10:20
    Cancer Etiology, Epidemiology & Risk Factors
    Short oral

    Background/Aim
    Hepatocellular carcinoma (HCC) is an increasingly common and highly lethal cancer that often develops through the progression of metabolic dysfunction-associated steatotic liver disease (MASLD), steatohepatitis (MASH), and cirrhosis. Physical activity and sleep influence key metabolic and inflammatory pathways along this disease continuum, yet the potential public health...

    Go to contribution page
  6. Yue Huang (International Agency for Research on Cancer)
    24/11/2026, 10:45
    Cancer Etiology, Epidemiology & Risk Factors
    Short oral

    Background: Emerging aetiological evidence has broadened the spectrum of diseases attributable to Epstein–Barr virus (EBV). Quantifying productivity losses from EBV-associated premature mortality can inform investment in research and prevention.
    Methods: We estimated productivity losses from premature mortality attributable to EBV across seven diseases in 185 countries and territories in...

    Go to contribution page
  7. Nirmala Prajapati (IARC)
    24/11/2026, 11:00
    Cancer Etiology, Epidemiology & Risk Factors
    Short oral

    Background: Evidence regarding associations between mobile phone use and headache or tinnitus remains inconclusive, despite the concerns of long-term health effects of RF-EMF exposure from mobile phone. We investigated the association of headache and tinnitus in the French component of the prospective Cohort Study of Mobile Phone Use and Health (COSMOS).
    Methods: Using the data from 11,973...

    Go to contribution page
  8. Lady Paola Aristizabal Arboleda (IARC)
    24/11/2026, 11:15
    Cancer Etiology, Epidemiology & Risk Factors
    Short oral

    Background: Lip cancer is rare and often grouped with oral cancer in epidemiological analyses due to its low caseload and shared risk factors, such as tobacco. However, ultraviolet (UV) radiation is also associated with cancer of the outer lip. To explore geographic variations and infer potential etiological drivers, this ecological study compared age-standardized incidence rates (ASIRs) and...

    Go to contribution page
  9. Rachel Wittenauer (IARC)
    24/11/2026, 11:30
    Cancer Etiology, Epidemiology & Risk Factors
    Short oral

    Background: Migration patterns are diversifying globally, and in 2024 over 5 million migrants arrived in the European Union (EU). Newly arrived migrants (defined here as individuals relocating into countries in the EU between 2020-2024) are identified by European Centre for Disease Prevention and Control (ECDC) as a priority population for entry health assessments. These assessments...

    Go to contribution page
  10. Cassandra Mbanje (IARC), Dr Errol Norwitz (Babson College)
    24/11/2026, 14:00

    Facilitated by Dr Errol Norwitz, this online workshop aims to help broaden and reframe perspectives on what a career in global health can look like as a researcher and stakeholder within a changing global health landscape. It also aims to help prepare you for your next interview – be it in academia, industry or a global organisation such as IARC.
    Topics covered include:
    • Knowing your WHY...

    Go to contribution page
  11. Lucie Simon (Université Lyon 1, Inserm U1290 Research on Healthcare Performance (RESHAPE), Lyon, France)
    25/11/2026, 09:45
    Cancer Screening, Early Detection & Health Systems
    Extended oral

    INTRODUCTION: Low-dose CT screening (LDCT) reduces lung cancer mortality by detecting tumours at earlier, more treatable stages, but implementing it is costly. Before France's pilot programme, IMPULSION, is extended nationwide, its efficiency needs to be established. We conducted a systematic review of European cost-effectiveness models of lung cancer screening, with methodological...

    Go to contribution page
  12. Dr Alice Barros Câmara (International Agency for Research on Cancer)
    25/11/2026, 10:05
    Cancer Screening, Early Detection & Health Systems
    Short oral

    Background: Organized cancer screening requires integrated information to identify the target population and ensure timely screening and diagnostic follow-up. In São Paulo, screening data are distributed across multiple information systems, limiting individual-level monitoring. This study describes SisConeCta-SP, an integrated information system developed to support organized breast and...

    Go to contribution page
  13. Tristan Thabuis (IARC)
    25/11/2026, 10:20
    Cancer Screening, Early Detection & Health Systems
    Short oral

    Background
    The ChildGICR educational program was created by the IARC and the St. Jude Children’s Research Hospital to build capacity and develop childhood cancer registration where it is lacking. We evaluated the impact of the programme on advances in childhood cancer registration.
    Methods
    A biphasic cross-sectional impact evaluation study was conducted using two questionnaires...

    Go to contribution page
  14. Miller Gnana Sundari Jeyachandran (IARC)
    25/11/2026, 10:35
    Cancer Screening, Early Detection & Health Systems
    Short oral

    Background: The benefits of cancer screening are realised only when effective organised cancer screening programmes (OCS) are sustainably implemented. Although several frameworks conceptualise sustainability, no practical assessment tool exists for OCS. EUCanScreen Work Package-4 aims to develop a consensus-based tool for this purpose.
    Methods: A four-stage modified Delphi study is being...

    Go to contribution page
  15. Meiwen Yuan (IARC)
    25/11/2026, 10:50
    Cancer Screening, Early Detection & Health Systems
    Short oral

    Aim
    Evidence on organized mammography breast cancer screening (BCS) reflects mainly overall effects. We aim to estimate age-specific breast cancer mortality reductions attributable to BCS.
    Methods
    This population-based difference-in-differences study paired countries by similarity and screening initiation. The earlier-initiating country served as the screening country and the...

    Go to contribution page
  16. Indira Adhikari (IARC)
    25/11/2026, 11:15
    Cancer Screening, Early Detection & Health Systems
    Short oral

    Background:
    Central nervous system (CNS) tumours represent 20% of all childhood cancers, with up to 40% non-malignant (nmCNS). Variations in reporting of nmCNS tumours by population-based cancer registries limit comparability.
    Objective:
    To analyse the impact of registering nmCNS tumours on incidence rates.
    Methods:
    All records of intracranial and intraspinal tumours were extracted...

    Go to contribution page
  17. Thao Tran (International Agency for Research on Cancer)
    25/11/2026, 11:30
    Cancer Screening, Early Detection & Health Systems
    Short oral

    Introduction: Current lung cancer screening criteria do not account for additional risk experienced by individuals exposed to occupational carcinogens.
    Method: We used data from the SYNERGY consortium, including 16,786 lung cancer cases and 20,818 controls and assessed exposure to lung carcinogens using a job-exposure matrix. We estimated odds ratios (ORs) of lung cancer for individuals...

    Go to contribution page
  18. Sathishrajaa Palaniraja (IARC)
    25/11/2026, 11:45
    Cancer Screening, Early Detection & Health Systems
    Short oral

    Background: Following the 2022 European Council recommendation to evaluate organised, risk-stratified prostate cancer (PCa) screening, the PRAISE-U (PRostate cancer Awareness and Initiative for Screening in the European Union) project implemented a risk-stratified screening protocol across five pilot sites. We assessed the conditions required to translate these pilots into sustainable...

    Go to contribution page
  19. Cassandra Mbanje (IARC)
    25/11/2026, 12:00
    Cancer Screening, Early Detection & Health Systems
    Short oral

    Background: Breast cancer is a leading cause of cancer mortality in Georgia (43 deaths per 100 000 in 2020), yet national screening uptake was only 16% in 2023. Our study examines patient-perceived and system barriers to early detection among self- and screen-detected women.
    Methods: DEDICA Georgia is a cross-sectional study that enrolled women aged ≥18 years with newly diagnosed breast...

    Go to contribution page
  20. Oliver Langselius (IARC)
    25/11/2026, 13:30
    Prevention Interventions, Policy & Public Health Impact
    Extended oral

    Background: Gastric cancer is one of the most common and deadly cancers globally and most cases are attributable to modifiable risk factors, particularly Helicobacter pylori infections. Survival remains low globally and varies between populations. We estimate the current and future avoidable deaths among people diagnosed with gastric cancer in 2024 to inform targeted gastric cancer...

    Go to contribution page
  21. Reisya Rizki Riantiningtyas (Institut Lyfe Research and Innovation Centre, 69130 Ecully, France)
    25/11/2026, 13:50
    Prevention Interventions, Policy & Public Health Impact
    Short oral

    Background: Sensory alterations and oral symptoms are common among patients undergoing cancer treatment and can negatively affect food intake, eating enjoyment, and quality of life. This study aimed to develop and evaluate sensory-customised foods designed for patients with cancer.
    Methods: Food concepts were developed and evaluated through a focus group discussion involving patients with...

    Go to contribution page
  22. Juliette Artignan (IARC)
    25/11/2026, 14:05
    Prevention Interventions, Policy & Public Health Impact
    Short oral

    Background: Alcohol causes an estimated 28,000 new cancer cases annually in France. According to the World Health Organisation, comprehensive alcohol marketing restrictions are a cost-effective policy to reduce alcohol consumption. Although the Loi Évin has restricted alcohol marketing in France since 1993, its public health impact depends in part on adequate monitoring and enforcement. This...

    Go to contribution page
  23. Taylor James Cromarty (IARC)
    25/11/2026, 14:20
    Prevention Interventions, Policy & Public Health Impact
    Short oral

    Gastric cancer is the 5th most common cause of cancer-related deaths worldwide; in Europe, 5-year relative survival is under 40%. The European Commission (EC) has launched initiatives to improve the approach to cancer prevention, screening, and care, with the aim of overcoming service inequality across Europe. In 2025, EC selected The International Agency for Research on Cancer to provide the...

    Go to contribution page
  24. Lays Silva de Azevedo (IARC)
    25/11/2026, 14:45
    Prevention Interventions, Policy & Public Health Impact
    Short oral

    Background: the COVID-19 pandemic disrupted cancer care worldwide, but evidence on its impact on treatment initiation is limited. Understanding how the pandemic affected cancer care is essential to strengthen the national health system during or outside of crises. Objective: to estimate the pandemic’s impact on outpatient chemotherapy initiation in Brazil for all cancers combined and...

    Go to contribution page
  25. Yann Becker (IARC)
    25/11/2026, 15:00
    Prevention Interventions, Policy & Public Health Impact
    Short oral

    Background
    Approximately 30% of cancers in Northern Europe are attributable to modifiable risk factors, yet the preventive potential of specific public health policies remains unquantified. We aimed to estimate the number of cancers that could be prevented by implementing evidence-based tobacco, alcohol, obesity and physical activity policies in six Nordic countries.
    Methods
    Using the...

    Go to contribution page
  26. Sathishrajaa Palaniraja (IARC)
    25/11/2026, 15:15
    Prevention Interventions, Policy & Public Health Impact
    Short oral

    Introduction: Cervical cancer is the second most common cancer among women in India, contributing to one-fifth of the world's cervical cancer burden and one-quarter of related deaths. HPV vaccination of adolescent girls is the first pillar of the WHO cervical cancer elimination strategy. Population-level introduction in India has been gradual and operational evidence for school-based delivery...

    Go to contribution page
  27. Muhammad Riedha (Hospices Civils de Lyon, Public Health Department, Epidemiology and Clinical Research Unit, 69002 Lyon, France)
    25/11/2026, 15:30
    Prevention Interventions, Policy & Public Health Impact
    Short oral

    Background: Clinical Trial Data Sharing (CTDS) for secondary use could improve research transparency and reproducibility. Despite journal and regulatory mandates, actual sharing of data remains rare. While 68.6% of trials intend to share data, under 1% make de-identified datasets public upon publication. CTDS is further hindered by privacy concerns, unharmonized data, and inadequate...

    Go to contribution page
  28. Naila Aba (IARC)
    Prevention Interventions, Policy & Public Health Impact
    Short oral

    A high-sodium, low-potassium diet is linked to increased gastric cancer risk, the fifth leading cause of cancer-related death worldwide. However, data on the identification of metabolites related to sodium or potassium exposure are limited. Thus, this study aims to identify urinary metabolites associated with 24-h urinary Sodium and Potassium excretion.

    We conducted a study within 363...

    Go to contribution page